For instance, in a PDX model of endocrine-resistant ER + breast cancer, researchers combined scRNA-seq with chromatin accessibility data, demonstrating that resistant tumor cells display heightened enhancer activity near transcription factors such as FOXC1 and SOX9, which promotes a stem-like phenotype (Dawoud et al., 2023). Here, SOX9 is linked to breast carcinoma.